Tailoring management strategies for the patient with menstrual migraine: focus on prevention and treatment.
Many women report an increased frequency of headaches around the time of menses. For some women, these headaches are more severe, of longer duration, and lead to greater disability than those occurring at other times in the menstrual cycle. A headache diary is critical to properly diagnose menstrual migraine (MM) by prospectively documenting headache days, severity of headache, and the headaches' relationship to menses. In women with diagnosed MM, acute treatment has been proven to be effective in randomized clinical trials. For those women who have predictable periods and may require preventive therapy, short-term prevention is a reasonable approach due to the predictability of MM. Although several agents (eg, naproxen sodium, magnesium, triptans) have been evaluated for prevention of MM, all but triptans have been assessed in small trials of between 20 and 35 women. Naratriptan, frovatriptan, and, most recently, zolmitriptan have been proven effective in preventing MM. Triptans are generally well tolerated, and the long-term safety of these agents is currently being evaluated. The flexibility of using acute and preventive therapy allows physicians to tailor treatment of MM and meet the needs of individual patients.
Tepper
Stewart J
SJ
Yale University School of Medicine, New Haven, CT, USA.
D005260:Female; D006801:Humans; D008598:Menstruation; D008881:Migraine Disorders / Q000175:diagnosis* / Q000209:etiology / Q000517:prevention & control / Q000628:therapy*; D014363:Tryptamines / Q000009:adverse effects / Q000627:therapeutic use
D014363:Tryptamines